Skip to content

WHWK WHWK Short-Term Investments

Short-Term Investments at other companies

Pfizer logo
PfizerPFE
$11.37B-28.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.79B+10.1%
Gilead Sciences logo
Gilead SciencesGILD
$15M
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$513.68M-8.7%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$317.88M+885%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$57.01M

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's short-term investments?
WHWK (WHWK) reported short-term investments of $88.25M in Q1 2026.
How has WHWK's short-term investments changed year-over-year?
WHWK's short-term investments increased by 2426.6% year-over-year, from $3.49M to $88.25M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.